KRISTLE CERO: Open Payments
NPI 1447780903 · MOORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 58 payments from 12 companies in 2025. Trend: 2023 $1,270 · 2024 $898 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $292 |
| Novo Nordisk Inc | 10 | $211 |
| AstraZeneca Pharmaceuticals LP | 8 | $192 |
| Paratek Pharmaceuticals, Inc. | 2 | $150 |
| Lilly USA, LLC | 6 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| PFIZER INC. | 3 | $56 |
| Exact Sciences Corporation | 3 | $43 |
| Astellas Pharma US Inc | 1 | $25 |
| Amgen Inc. | 1 | $22 |
Products named: UBRELVY, AIRSUPRA, NUZYRA, MOUNJARO, QULIPTA, REXULTI, Rybelsus, Wegovy.
Industry payments across OK — which companies pay providers there.
